Tech Company Financing Transactions
HistoSonics Funding Round
On 8/15/2024, HistoSonics secured $102 million in Series D investment from Alpha Wave Ventures, Amzak Health Investors and HealthQuest Capital.
Transaction Overview
Company Name
Announced On
8/15/2024
Transaction Type
Venture Equity
Amount
$102,000,000
Round
Series D
Investors
Proceeds Purpose
The Series D funding will be used to accelerate advancements to its non-invasive histotripsy platforms, support commercial growth in the US and in planned global markets, and initiate the company's innovative, prospective BOOMBOX Master Study that will evaluate HistoSonics' Edison System for the treatment of liver tumors across multidisciplinary users.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3526 West Liberty Rd. 100
Ann Arbor, MI 48103
USA
Ann Arbor, MI 48103
USA
Phone
Website
Email Address
Overview
HistoSonics Inc. is a new medical device company that is developing histotripsy, a non-invasive, image-guided therapeutic ultrasound technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Michael Blue
Chief Financial Officer
Eric Bosler
Vice President
Michele Bossert
VP - Marketing
Josh King
VP - Operations
Daniel Bulver
VP - R & D
Josh Stopek
VP - Regulatory Affairs
Daniel Kosednar
VP - Sales
Jonathon Pons
Browse more venture capital transactions:
Prev: 8/15/2024: Ferretly venture capital transaction
Next: 8/15/2024: JetZero venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site come from a variety of public sources. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs